Literature DB >> 11170226

Hydroxyurea-induced oxidative damage of normal and sickle cell hemoglobins in vitro: amelioration by radical scavengers.

E W Iyamu1, H Fasold, D Roa, M del Pilar Aguinaga , T Asakura, E A Turner.   

Abstract

Hydroxyurea (HU) induces fetal hemoglobin (Hb F) production in patients with sickle cell anemia. The therapeutic dosage of HU used for Hb F induction often elicits myelosuppression, which becomes its major associated complication. We examined the effect of HU on hemoglobin modulation and the role of radical scavengers on these induced changes. In vitro exposure of human blood to various concentrations of HU at predetermined time intervals induced a progressive dose-dependent oxidation (MetHb formation) of both adult (Hb AA) and sickle (Hb SS) hemoglobins. The oxidative effect of HU on Hb SS was 3 times greater than its effect on Hb AA. Similar but less profound changes were observed in H2O2-treated samples. Hb F was, however, observed to be relatively resistant to HU-induced oxidative damage. A substantial protective effect of Hb by alpha-tocopherol, ascorbic acid, and D-mannitol was observed during pretreatment of Hb AA and Hb SS blood samples. Analyses of the hemoglobins and their globin chain components by high-performance liquid chromatography revealed a considerable protective effect by these free radical scavengers. These results indicate that the HU-induced damage of hemoglobin and their component globin chains can be reduced by radical scavengers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170226     DOI: 10.1002/1098-2825(2001)15:1<1::aid-jcla1>3.0.co;2-i

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  7 in total

1.  Oxidative stress assessment in sickle cell anemia patients treated with hydroxyurea.

Authors:  Cristiane O Renó; Amanda Rodrigues Barbosa; Sara Santos de Carvalho; Melina B Pinheiro; Danyelle Romana Rios; Vanessa F Cortes; Leandro A Barbosa; Hérica L Santos
Journal:  Ann Hematol       Date:  2020-03-12       Impact factor: 3.673

Review 2.  The proteome of sickle cell disease: insights from exploratory proteomic profiling.

Authors:  Susan Yuditskaya; Anthony F Suffredini; Gregory J Kato
Journal:  Expert Rev Proteomics       Date:  2010-12       Impact factor: 3.940

Review 3.  Sickle cell disease and the kidney.

Authors:  Jon I Scheinman
Journal:  Nat Clin Pract Nephrol       Date:  2008-12-02

Review 4.  Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome.

Authors:  Swati S Ghatpande; Pankaj K Choudhary; Charles T Quinn; Steven R Goodman
Journal:  Exp Biol Med (Maywood)       Date:  2008-10-10

5.  Shoutai pills improve the quality of oocytes exposed to the chemotherapeutic drug Hydroxyurea.

Authors:  Yuwei Zhang; Ruizhi Tan; Li Wang; Xiaoyan Shi; Yu Li; Xia Zhong; Xiaoxia He; Bo Xiong
Journal:  Aging (Albany NY)       Date:  2020-05-10       Impact factor: 5.682

6.  Comment on "The influence of hydroxyurea on oxidative stress in sickle cell anemia".

Authors:  Eduard Johannes van Beers; Gregory James Kato
Journal:  Rev Bras Hematol Hemoter       Date:  2012

7.  Hydroxyurea Scavenges Free Radicals and Induces the Expression of Antioxidant Genes in Human Cell Cultures Treated With Hemin.

Authors:  Sânzio Silva Santana; Thassila Nogueira Pitanga; Jeanne Machado de Santana; Dalila Lucíola Zanette; Jamile de Jesus Vieira; Sètondji Cocou Modeste Alexandre Yahouédéhou; Corynne Stéphanie Ahouefa Adanho; Sayonara de Melo Viana; Nivea Farias Luz; Valeria Matos Borges; Marilda Souza Goncalves
Journal:  Front Immunol       Date:  2020-07-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.